CANDA, T. Et Al. 2018. Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study. european journal of breast health , vol.14 , 160-165.

CANDA, T., YAVUZ, E., ÖZDEMİR, N., İLVAN, Ş., DİZBAY SAK, S., GÜRAY DURAK, M., ... TUZLALI, H. S. (2018). Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study. european journal of breast health , vol.14, 160-165.

CANDA, TÜLAY Et Al. "Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study," european journal of breast health , vol.14, 160-165, 2018

CANDA, TÜLAY Et Al. "Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study." european journal of breast health , vol.14, pp.160-165, 2018

CANDA, T. Et Al. (2018) . "Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study." european journal of breast health , vol.14, pp.160-165.

@article{article, author={TÜLAY CANDA Et Al. }, title={Immunohistochemical HER2 Status Evaluation in Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study}, journal={european journal of breast health}, year=2018, pages={160-165} }